Although serum ApN in healthy people might be associated with vascular function independently of insulin resistance, increased inflammatory markers are connected with an increase in insulin resistance in patients with impaired glucose tolerance, type 2 diabetes, and obesity, who also have low circulating ApN concentrations [2, 5–7]. This evidence concerns the gene ANPEP and obesity due to melanocortin 4 receptor deficiency.